In the last few years, there has been much discussion on the usefulness of the PSA test both as a diagnostic and prognostic factor for prostate cancer.

We are a spin-off of the University of Turin (Italy) focused on the search and validation of new biomarkers for prostate cancer.

We are interested in knowing the needs of professionals who deal with prostate diseases every day and in what direction the research and development of new technologies should be concentrated.

The data you provide us will be collected and analyzed only by the research team for the purposes related to the project and will not be disclosed to third parties.

For any questions or communications, you can contact us at: comunicazione@nibbiotec.com
or visit our website: www.nibbiotec.com